logo True scholar network
Back to Top
Visit Website

Cancer Biology & Therapy (CBT)

Publisher :

Taylor & Francis

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • Cancer Biology & Therapy
  • exchange of information
  • Pharmacogenomics

    • +8

e-ISSN :

1555-8576

Issue Frequency :

Continuously

Impact Factor :

4.4

p-ISSN :

1538-4047

Est. Year :

2002

Mobile :

4402080520500

DOI :

YES

Country :

India

Language :

English

APC :

YES

Impact Factor Assignee :

google scholar

Email :

enquiries@taylorandfrancis.com

Journal Descriptions

Cancer Biology & Therapy is a high-profile international journal examining all aspects of the molecular basis of cancer, with translational relevance to diagnosis and therapy. The goal is to foster communication and the rapid exchange of information through timely publication of important advances within the field. Topics covered include: Existing and emerging technologies such as genome sequencing to increase understanding of genomic and proteomic alterations occurring within tumors; Tumor pathogenesis, development and progression; Drug-drug interactions; mechanisms of action for novel agents; combination chemotherapy; Pharmacogenomics, pharmacodynamics, and pharmacokinetic properties of anticancer agents; Anticancer chemotherapeutic agents, biological agents, immunomodulatory drugs, cell therapy and gene therapy.


Cancer Biology & Therapy (CBT) is :

International, Peer-Reviewed, Open Access, Refereed, Cancer Biology & Therapy, exchange of information, Pharmacogenomics, pharmacodynamics, pharmacokinetic properties of anticancer, relevance to diagnosis and therapy, research, reviews, meeting reports, bedside-to-bench reports, letters to the editor , Online or Print, Continuously Journal

UGC Approved, ISSN Approved: P-ISSN - 1538-4047, E-ISSN - 1555-8576, Established in - 2002, Impact Factor - 4.4

Provide Crossref DOI

Indexed in Scopus, WoS

Not indexed in DOAJ, PubMed, UGC CARE

Indexing

Scopus Profile
Scopus
Scopus Profile
WoS
Scopus Profile
Crossref

+1 More

Publications of CBT

  • dott image December, 2024

First-line treatments for KRAS-mutant non-small cell lung cancer: current state and future perspectives

KRAS mutations are common in non-small cell lung cancer (NSCLC) and are associated with patient prognosis; however, targeting KRAS has faced various difficulties. Currently, immunotherapy, c...

  • dott image December, 2024

Long-term effects of neoadjuvant chemotherapy in variant histology locally advanced colon cancer: a propensity score-matched analysis

Purpose Neoadjuvant chemotherapy (NAC) has proven valuable in treating locally advanced colon cancer (LACC) and is included as a treatment option for patients with clinical T4b colon cancer...

  • dott image December, 2024

Daurisoline inhibits glycolysis of lung cancer by targeting the AKT-HK2 axis

Lung cancer, one of the most prevalent tumors, remains a clinical challenge with a poor five-year survival rate. Daurisoline, a bis-benzylisoquinoline alkaloid derived from the traditional C...

  • dott image December, 2024

Knockdown of NDUFAF6 inhibits breast cancer progression via promoting mitophagy and apoptosis

Background While NDUFAF6 is implicated in breast cancer, its specific role remains unclear. Methods The expression levels and prognostic significance of NDUFAF6 in breast cancer were as...

  • dott image Yuehua Liu
  • dott image January, 2025

Effect of extracellular vesicle ZNF280B derived from lung cancer stem cells on lung cancer progression

Objective The purpose of this research was to investigate the role of extracellular vesicles derived from lung cancer stem cells (lung CSCs-EVs) in lung cancer and to explore their potentia...

  • dott image January, 2025

NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia

Cell cycle dysregulation and the corresponding metabolic reprogramming play significant roles in tumor development and progression. CDK9, a kinase that regulates gene transcription and cell ...

  • dott image January, 2025

RSK4 promotes the metastasis of clear cell renal cell carcinoma by activating RUNX1-mediated angiogenesis

Ribosomal S6 protein kinase 4 (RSK4), a member of the serine‒threonine kinase family, plays a vital role in the Ras‒MAPK pathway. This kinase is responsible for managing several cellular...

  • dott image January, 2025

Sigma1 inhibitor suppression of adaptive immune resistance mechanisms mediated by cancer cell derived extracellular vesicles

Adaptive immune resistance in cancer describes the various mechanisms by which tumors adapt to evade anti-tumor immune responses. IFN-γ induction of programmed death-ligand 1 (PD-L1) was th...

  • dott image January, 2025

Fractionated radiotherapy initiated at the early stage of bone metastasis is effective to prolong survival in mouse model

Background and purpose Bone metastasis is common for breast cancer and associated with poor prognosis. Currently, radiotherapy (RT) serves as the standard treatment for patients exhibiting ...

  • dott image January, 2025

miR-301a-mediated crosstalk between the Hedgehog and HIPPO/YAP signaling pathways promotes pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) poses a significant challenge in oncology due to its dismal prognosis and limited therapeutic options. In this study, we investigated the role of miR-...

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile